10.19.2015
This article was translated by an automatic translation system, and was therefore not reviewed by people.
transparent image
According to a survey conducted by Anvisa, no drug registration process was submitted to the Agency for the phosphoethanolamine may be considered a drug. The step is essential for the efficacy and safety of the product can be evaluated based on scientific criteria accepted worldwide.
According to the Agency published Technical Note also there is no research protocol on the product, milestone prior to the registration of any medicine.
Check out the Agency's Technical Note on phosphoethanolamine
Source: Anvisa
To access the Anvisa site, click here.
Our news are taken in full of our partner sites. For this reason, we can not change their content even in cases of typographical errors.
transparent image
This article was translated by an automatic translation system, and was therefore not reviewed by people.